Different Effects of L/N-Type and L-Type Calcium Channel Blockers on the Renin-Angiotensin-Aldosterone System in SHR/Izm

被引:36
作者
Konda, Tomoyuki [1 ]
Enomoto, Azusa [1 ]
Aritomi, Shizuka [1 ]
Niinuma, Kazumi [1 ]
Koganei, Hajime [1 ]
Ogawa, Tetsuya [2 ]
Nitta, Kosaku [2 ]
机构
[1] Ajinomoto Co Inc, Pharmaceut Res Labs, Kawasaki Ku, Kanagawa 2109681, Japan
[2] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan
关键词
Hypertension; Calcium channel blocker; N-type; Cilnidipine; Aldosterone; CILNIDIPINE; SECRETION; BLOCKADE; STIMULATION; ANTAGONIST; EXPRESSION;
D O I
10.1159/000210396
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The L/N-type calcium channel blocker (CCB) cilnidipine has been demonstrated to suppress sympathetic nerve activity. In the present study, we investigated the effects of cilnidipine on the renin-angiotensin-aldosterone system (RAAS) in SHR/Izm rats to confirm differences from the effects of L-type CCB. Methods: Male SHR/Izm rats received vehicle, cilnidipine (0.3, 3 mg/kg) or amlodipine (0.3, 3 mg/kg) by gavage for systolic blood pressure (SBP) measurement. For biochemical analyses, the experiments were performed under anesthesia. Results: Low doses of cilnidipine or amlodipine had no effect on SBP or RAAS parameters. A high dose of either drug produced similar effects on SBP levels. Although cilnidipine had no effect on plasma renin activity or the plasma angiotensin II level, amlodipine significantly increased these parameters as compared to levels in the vehicle group. The cilnidipine group had a significantly lower plasma aldosterone level and renal cortical tissue norepinephrine level than the vehicle group. Conclusions: Cilnidipine had effects different from those of L-type CCB on the RAAS in SHR/Izm rats. Our results indicate that suppression of RAAS hyperactivity by cilnidipine can be partly explained by its sympatholytic action. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:155 / 161
页数:7
相关论文
共 23 条
[1]   Neural control of renal function [J].
DiBona, GF ;
Kopp, UC .
PHYSIOLOGICAL REVIEWS, 1997, 77 (01) :75-197
[2]   Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases [J].
Fogo, AB .
KIDNEY INTERNATIONAL, 2000, 57 :S15-S21
[3]  
Fujii S, 1997, J PHARMACOL EXP THER, V280, P1184
[4]   Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction [J].
Greenberg, Barry ;
Zannad, Faiez ;
Pitt, Bertram .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10A) :34F-40F
[5]   DOMINANT ROLE OF N-TYPE CA-2+ CHANNELS IN EVOKED RELEASE OF NOREPINEPHRINE FROM SYMPATHETIC NEURONS [J].
HIRNING, LD ;
FOX, AP ;
MCCLESKEY, EW ;
OLIVERA, BM ;
THAYER, SA ;
MILLER, RJ ;
TSIEN, RW .
SCIENCE, 1988, 239 (4835) :57-61
[6]   Beta-adrenergic stimulation of renin expression in vivo [J].
Holmer, SR ;
Kaissling, B ;
Putnik, K ;
Pfeifer, M ;
Kramer, BK ;
Riegger, GAJ ;
Kurtz, A .
JOURNAL OF HYPERTENSION, 1997, 15 (12) :1471-1479
[7]   INHIBITORY EFFECT OF CILNIDIPINE ON PRESSOR-RESPONSE TO ACUTE COLD STRESS IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
HOSONO, M ;
HIRUMA, T ;
WATANABE, K ;
HAYASHI, Y ;
OHNISHI, H ;
TAKATA, Y ;
KATO, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (02) :119-125
[8]   Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells [J].
Imagawa, K ;
Okayama, S ;
Takaoka, M ;
Kawata, H ;
Nava, N ;
Nakajima, T ;
Horii, M ;
Uemura, S ;
Saito, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 (01) :133-138
[9]   Sympathetic nerve activity is inappropriately increased in chronic renal disease [J].
Klein, IHHT ;
Ligtenberg, G ;
Neumann, J ;
Oey, PL ;
Koomans, HA ;
Blankestijn, PJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12) :3239-3244
[10]   Effects of a dual L/N-type Ca2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs [J].
Konda, T ;
Takahara, A ;
Maeda, K ;
Dohmoto, H ;
Yoshimoto, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (01) :117-120